leadf
logo-loader
CSE:MSET OTCQB:MSSTF FRA:9DF

Mindset Pharma Inc

Receive alerts
Market:
CSE
Market Cap:
$60.66 m
Price
0.84 CAD
Change
3.70%
52 weeks high
2.20
52 weeks low
0.33

In brief

Mindset Pharma is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. The company was established to develop next-generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Mindset is developing several novel families of next generation psychedelic compounds, as well as an innovative process to chemically synthesize psilocybin along with its own proprietary compounds.

Snapshot

  • Mindset Pharma says further preclinical results for its MSP-4018 drug candidate demonstrate strong efficacy and improved safety profile
  • Maxim Group hikes price target for Mindset Pharma to US$1.50 after the company develops a specialized preclinical rodent model
  • Mindset Pharma say latest results further validate lead candidate's comparison to psilocybin